Imbalance of Brain Monoamines and Clinical Disorders
- 1 January 1982
- book chapter
- Published by Elsevier
- Vol. 55, 419-429
- https://doi.org/10.1016/s0079-6123(08)64212-0
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamineNeuroscience Letters, 1979
- Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Tryptophan‐nicotinamide, imipramine and their combination in depressionActa Psychiatrica Scandinavica, 1979
- Neuroendocrine and amine studies in affective illnessPsychoneuroendocrinology, 1977
- Development of β-adrenergic receptor subsensitivity by antidepressantsNature, 1977
- Comparative trial of L-tryptophan and amitriptyline in depressive illnessPsychological Medicine, 1977
- DISTRIBUTION OF CHOLINE ACETYLTRANSFERASE AND GLUTAMATE DECARBOXYLASE WITHIN THE SUBSTANTIA NIGRA AND IN OTHER BRAIN REGIONS FROM CONTROL AND PARKINSONIAN PATIENTSJournal of Neurochemistry, 1975
- MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized SleepScience, 1973
- L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa TherapyNature, 1973
- Herabgesetzte Konzentration der Homovanillinsäure im Gehirn von parkinsonkranken Menschen als Ausdruck der Störung des zentralen DopaminstoffwechselsKlinische Wochenschrift, 1965